Led by Steven D. Kunkel, MD, the TrialNet team at Kadlec Medical Center Diabetes Learning Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. 

Note: As a TrialNet affiliate, Kadlec Medical Center Diabetes Learning Center is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Ana Creo, MD, the TrialNet team at Mayo Clinic is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Mayo Clinic is regionally overseen by University of Minnesota. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Susanne Cabrera, MD, the TrialNet team at Medical College of Wisconsin is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Medical College of Wisconsin is regionally overseen by Indiana University - Riley Hospital. If you reach out to TrialNet, you may be contacted by staff from either institution.

Led by Dr. Mary Pat Gallagher, the TrialNet team at NYU Langone Long Island DBA Pediatric Diabetes Program is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, NYU Langone Long Island DBA Pediatric Diabetes Program is regionally overseen by Columbia University. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Rodica Busui MD, PhD, the TrialNet team at Oregon Health and Science University is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Oregon Health and Science University is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution

Led by Elaine M. Apperson MD, FAAP, the TrialNet team at Pediatric Endocrinology, Prisma Health—Upstate Children’s Hospital is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Pediatric Endocrinology, Prisma Health—Upstate Children’s Hospital is regionally overseen by University of Florida. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Christopher Kishiyama, MD, the TrialNet team at Providence Sacred Heart Medical Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Providence Sacred Heart Medical Center is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Associate Professor Tony Huynh, the TrialNet team at Queensland Children's Hospital is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Queensland Children's Hospital is regionally overseen by Walter and Eliza Hall Institute of Medical Research. If you reach out to TrialNet, you may be contacted by staff from either institution

Led by Jose Bernardo Quintos, MD, the TrialNet team at Rhode Island Hospital is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. 

Note: As a TrialNet affiliate, Rhode Island Hospital is regionally overseen by Yale University School of Medicine. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Riley Hospital for Children is one of eighteen Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Principal Investigator, Linda DiMeglio, MD, the TrialNet team at the Riley's is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.